Skip to content

Patient Utilization of Opioid Destruction Bags in the Post-op Period

Patient Utilization of Opioid Destruction Bags in the Post-op Period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05875857
Enrollment
163
Registered
2023-05-25
Start date
2023-06-19
Completion date
2027-01-01
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use, Opioid Use, Unspecified, Patient Empowerment, Total Hip Arthroplasty, Total Knee Arthoplasty

Brief summary

This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.

Detailed description

This is a randomized single-center prospective survey study to describe the utilization of opioid destruction bags in the post-operative period. Participants who underwent surgery for Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) will be eligible for inclusion if discharging to home with an opioid prescription. Eligible participants will be randomized between two groups: 1) Control group will receive current standard of care 2) Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Participants will be phoned/emailed six to eight weeks post-surgery to complete a survey. Attempts will be made on three separate days to reach the participant via phone. If email is preferred, three reminders will be sent to complete the survey. If participant is unreachable, they will be considered lost to follow up. Survey questions will be comprised of various question styles, including: yes/no, multiple choice, and free text answers.

Interventions

BEHAVIORALOpioid destruction education

Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge.

Sponsors

University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

19 years of age or older Discharging to home and prescribed opioids at discharge post total knee arthroplasty or total hip arthroplasty

Exclusion criteria

Under 19 years of age Opioid medication use prior to surgery Not prescribed an opioid to take after discharge

Design outcomes

Primary

MeasureTime frameDescription
Opioid destructionSix to Eight weeks post dischargeNumber of patients who report they did or plan to destroy unused opioids

Secondary

MeasureTime frameDescription
Patient EducationSix to Eight weeks post dischargeNumber of patients who recall patient education on storage and disposal of opioid medications at discharge
Opioid StorageSix to Eight weeks post dischargeType of opioid storage method used at home
Opioid Destruction MethodSix to Eight weeks post dischargeType of opioid destruction method used or plan to use
Leftover PillsSix to Eight weeks post dischargeEstimated number of pills leftover after completion of therapy

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKristin R Daniel, PharmD

University of Nebraska

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026